ICD-10-CM Billable Code

F40.00

Agoraphobia, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Agoraphobia, classified under ICD-10 code F40.00, is a type of anxiety disorder characterized by an intense fear of open or crowded spaces. This condition can significantly interfere with daily activities and can cause sufferers to avoid situations that might trigger anxiety, leading to limitations in social, occupational, and personal functioning. While often associated with panic attacks, agoraphobia specifically centers on fears related to certain environments and situations where escape might be difficult or help might not be readily available.

Causes & Symptoms

Clinical Causes: Genetic predisposition and family history of anxiety or mood disorders Traumatic or stressful events, such as physical or emotional abuse History of panic attacks or other anxiety disorders Significant life changes or transitions, such as moving or divorce Personality traits, including a tendency toward shyness or avoidance Chemical imbalances in the brain, particularly involving serotonin and norepinephrine

Key Symptoms: Persistent fear or anxiety about being in places where escape might be difficult Avoidance of crowded places, malls, bridges, or public transportation Feeling trapped or helpless in certain situations Physical symptoms such as rapid heartbeat, sweating, trembling, or dizziness when exposed to feared environments Anticipatory anxiety about upcoming outings or social events Dependence on a trusted companion or family member to venture outside Significant distress or impairment in social, occupational, or other important areas of functioning

Diagnostic & Treatment

Diagnosis Path: Diagnosis of agoraphobia involves a thorough assessment by a mental health professional, including a detailed clinical interview focused on the individual's symptoms, history, and impact on daily life. Diagnostic criteria typically require persistent fear or anxiety about at least two situations, such as public transportation, open spaces, enclosed spaces, standing in line, or being outside the home alone, lasting for six months or more. The clinician may also rule out other causes for symptoms, such as medical conditions or substance use.

Treatment Protocols: Effective management of agoraphobia often involves a combination of therapies and, in some cases, medications. Common approaches include: - **Psychotherapy**: Cognitive-behavioral therapy (CBT) is widely regarded as the most effective treatment, helping individuals confront fears gradually and develop coping strategies. - **Medication**: Selective serotonin reuptake inhibitors (SSRIs) or benzodiazepines may be prescribed to reduce anxiety symptoms, typically under careful medical supervision. - **Self-help strategies**: Relaxation techniques, mindfulness practices, and gradual exposure exercises can assist in symptom management. - **Support groups**: Connecting with others experiencing similar challenges may provide additional emotional support and practical advice. Treatment plans are tailored to each individual's needs and may require ongoing adjustments to optimize outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F40.00 a billable ICD-10 code?
Yes, F40.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F40.00?
Clinical documentation must specify the nature of Agoraphobia, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference